First National Bank of Hutchinson’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,764
Closed -$557K 84
2016
Q2
$557K Sell
6,764
-2,243
-25% -$199K 0.37% 42
2016
Q1
$828K Sell
9,007
-2,856
-24% -$258K 0.52% 33
2015
Q4
$1.21M Buy
11,863
+1,447
+14% +$151K 0.78% 16
2015
Q3
$1.02M Buy
10,416
+813
+8% +$90.3K 0.7% 20
2015
Q2
$1.14M Sell
9,603
-2,638
-22% -$288K 0.73% 19
2015
Q1
$1.2M Buy
12,241
+119
+1% +$12.1K 0.67% 18
2014
Q4
$1.14M Buy
12,122
+327
+3% +$33.8K 0.66% 18
2014
Q3
$1.26M Buy
11,795
+78
+0.7% +$7.64K 0.77% 15
2014
Q2
$971K Buy
11,717
+874
+8% +$68K 0.59% 18
2014
Q1
$768K Buy
10,843
+2,544
+31% +$200K 0.48% 21
2013
Q4
$623K Buy
8,299
+790
+11% +$55K 0.41% 24
2013
Q3
$472K Sell
7,509
-3,871
-34% -$231K 0.33% 30
2013
Q2
$583K Buy
+11,380
New +$593K 0.21% 48

Other funds holding GILD

First National Bank of Hutchinson's GILD Position: Q3 2016 in Review

First National Bank of Hutchinson sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 6,764 shares — an estimated $557K sold.

First National Bank of Hutchinson first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $1.26M in Q3 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • First National Bank of Hutchinson reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • First National Bank of Hutchinson sold 6,764 Gilead Sciences shares in Q3 2016, an estimated $557K.
  • First National Bank of Hutchinson first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • First National Bank of Hutchinson's Gilead Sciences position peaked at $1.26M in Q3 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on First National Bank of Hutchinson's 13F filing for Q3 2016, filed 21 Oct 2016.